AwardTape · Defense awards · Research and development · Health R&D · W81XWH22D0013
W81XWH22D0013: $0 IDIQ contract to Emory University
Emory University holds an IDIQ contract from Defense Health Agency with $0 obligated since Oct 2023, against a ceiling of $764K. Latest action Feb 28, 2024.
Services for usamriid generation of monoclonal antibodies (mabs)
| PIID | W81XWH22D0013 |
|---|---|
| Type | IDIQ contract |
| Company | Emory University |
| Agency | Defense Health Agency |
| Contracting office | ARMY MED RES ACQ ACTIVITY |
| Category | Research and development · Health R&D |
| PSC | AN41 HEALTH R&D SERVICES; HEALTH CARE - OTHER; BASIC RESEARCH |
| NAICS | 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| Obligated since Oct 2023 | $0 |
| Total obligated (lifetime) | $0 |
| Ceiling (base and all options) | $764K |
| Base date | Sep 1, 2022 |
| Latest action | Feb 28, 2024 |
| End date | n/a |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Not competed under simplified acquisition |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial